Systemic adjuvant therapy in mammographically discovered invasive cancer.
Most mammographically discovered invasive breast cancers are 1 cm or smaller in diameter. These cancers have such a favorable prognosis that systemic therapy may be inappropriate. Special histologies, micrometastatic deposits in axiliary lymph nodes, and lesions of borderline size all pose special problems of interpretation relative to the role of systemic therapy.
Wood
W C
WC
Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008327:Mammography; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen